Kazia Therapeutics Ltd
KZIA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001075880
No open-market purchases or sales by Kazia Therapeutics Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $50.7M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Kazia Therapeutics Ltd as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- 0 vs. Q1 2022
- Shares held
- 294.4K
- −81.7K (−21.7%) vs. Q1 2022
- Total value
- $1.24M
- −$1.66M (−57.4%) vs. Q1 2022
- New holders
- 3
- 0 more added
- Sold out
- 3
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZIA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $50.7M |
| Q1 2026 | 23 | $13.0M |
| Q4 2025 | 22 | $17.1M |
| Q3 2025 | 11 | $1.14M |
| Q2 2025 | 10 | $902.9K |
| Q1 2025 | 10 | $120.9K |
| Q4 2024 | 11 | $569.1K |
| Q3 2024 | 18 | $922.0K |
| Q2 2024 | 11 | $89.5K |
| Q1 2024 | 11 | $115.5K |
| Q4 2023 | 18 | $2.15M |
| Q3 2023 | 10 | $235.9K |
| Q2 2023 | 9 | $327.6K |
| Q1 2023 | 8 | $279.4K |
| Q4 2022 | 10 | $262.0K |
| Q3 2022 | 9 | $527.0K |
| Q2 2022 | 12 | $1.24M |
| Q1 2022 | 12 | $2.90M |
| Q4 2021 | 12 | $4.01M |
| Q3 2021 | 18 | $5.03M |
| Q2 2021 | 15 | $4.35M |
| Q1 2021 | 14 | $4.60M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Kazia Therapeutics Ltd; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 201,605 | $846.0K | 0.00% | −91,771−31.3% | Reduced |
| Envestnet Asset Management Inc | 26,411 | $111.0K | 0.00% | −10.0% | Reduced |
| Two Sigma Securities, LLC | 24,735 | $104.0K | 0.02% | +24,735 | New |
| Citadel Advisors LLC | 22,769 | $95.0K | 0.00% | +22,769 | New |
| SG Americas Securities, LLC | 13,988 | $59.0K | 0.00% | −9,911−41.5% | Reduced |
| UBS Group AG | 2,470 | $10.0K | 0.00% | +2,470 | New |
| Simplex Trading, LLC | 994 | $4.00K | 0.00% | −3,917−79.8% | Reduced |
| Royal Bank of Canada | 1,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 200 | $1.00K | 0.00% | −300−60.0% | Reduced |
| Cordasco Financial Network | 125 | $1.00K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| AdvisorNet Financial, Inc | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −25,050−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −613−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |